Regional Infusion Chemotherapy for Colorectal Hepatic Metastases

  • John M. Daly
  • Nancy Kemeny
Part of the Developments in Oncology book series (DION, volume 42)

Summary

Large bowel cancer is the second most common malignancy with the liver being the predominate site of distant metastases. Prospective studies evaluating the natural history of advanced disease suggest a median survival of five to six months, however, there is a wide range depending upon the extent of hepatic involvement. Disappointment with systemic chemotherapy has led to increased investigations regarding regional therapy directed at the liver. In the past, improved response rates have been noted with hepatic arterial infusion chemotherapy, however, complications of the technique have not led to widespread acceptance. Use of an implantable pump has decreased technical and infectious complications associated with this method of treatment. A phase II trial at Memorial Sloan Kettering Cancer Center showed that previously untreated patients had a response rate of 50% while in previously treated patients the response rate was 31%. Toxicity involved the gastrointestinal tract with chemical hepatitis and gastritis being the predominate manifestations. Further, prospective clinical trials of intraarterial chemotherapy for colorectal hepatic metastases are indicated to provide definitive conclusions regarding tumor response rates, length of patient survival, cost, morbidity, and quality of life during treatment.

Keywords

Hepatic Artery Hepatic Metastasis Gastroduodenal Artery Tumor Response Rate Hepatic Arterial Infusion Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Foster JH, Lungy J: Liver metastases. Curr Prob Surg 18: 160–195, 1983.Google Scholar
  2. 2.
    Jaffe BM, Donegan WL, Watson F, Spratt JS: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127: 1–11, 1968.PubMedGoogle Scholar
  3. 3.
    Wood CB, Gillis CR, Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2: 285–288, 1976.PubMedGoogle Scholar
  4. 4.
    Wagner JS, Adson MA, Van heerden JA, Adson MH, Ilstrup DM: The natural history of hepatic metastases from colorectal cancer. Ann Surg 199: 502–508, 1984.PubMedCrossRefGoogle Scholar
  5. 5.
    Kemeny N, Braun DW: Prognostic factors in advanced colorectal carcinoma: Importante of lactic dehydrogenase, performance status and white blood cell count. Amer J Med 74: 786–797, 1983.PubMedCrossRefGoogle Scholar
  6. 6.
    Kemeny N: Systemic chemotherapy of hepatic metastases. Semin Oncol 10: 148–158, 183.Google Scholar
  7. 7.
    Daly JM, Kemeny N, Oderman P, Botet J: Chronic hepatic arterial infusion chemotherapy: Anatomical considerations, operative management and treatment morbidity. Arch Surg 119: 936–941, 1984.PubMedGoogle Scholar
  8. 8.
    Ansfield FJ, Ramirez G, Davis HL, Wirtanen GW, Johnson RO, Bryan GT, Manalo FB, Borden EC, Davis TE, Esmaili M: Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil. Cancer 36: 24l3–2417, 1975.Google Scholar
  9. 9.
    Dahl EP, Fredlund PE, Tylen U, Bengmark S: Transient hepatic dearterialization followed by regional intraarterial 5-fluorouracil infusion as treatment for liver tumors. Ann Surg 193: 82–88, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Fortner JG, Mulcare RJ, Soils A, Watson RC, Golbey RB: Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg 178: 162–172, 1973.PubMedCrossRefGoogle Scholar
  11. 11.
    Clarkson B, Young C, Dierick W, Kuehn P, Kim M, Berrett A, Clapp P, Lawrence W: Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver. Cancer 15: 472–488, 1962.PubMedCrossRefGoogle Scholar
  12. 12.
    Sullivan RD, Norcross JW, Watkins E: Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 270: 321–327, 1964.PubMedCrossRefGoogle Scholar
  13. 13.
    Crowley ML: Penetrating duodenal ulcer associated with an operatively implanted arterial chemotherapy infusion catheter. Gastroenterology 83: 118–120, 1982.PubMedGoogle Scholar
  14. 14.
    Reed ML, Vaitkevicius VK, Al-Sarraf M, Vaugn CB, Singhakowinta A, Sexon-Porte M, Izbicki R, Baker L, Straatsma GW: The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocol. Cancer 47: 402–409, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Buchwald H, Grage TB, Vassilopoulos PP, Rhode TD, Varco RL, Blackshear PJ: Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45: 866–869, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Balch CM, Urist MM, McGregor ML: Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg l45: 285–290, 1983.CrossRefGoogle Scholar
  17. 17.
    Balch CM, Urist MM, Soong SJ, McGregor M: A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198: 567–573, 1983.PubMedCrossRefGoogle Scholar
  18. 18.
    Ensminger W, Niederhuber J, Dakhil S, Thrail J, Wheeler R: Totally implantated drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 5: 393–400, 1981.Google Scholar
  19. 19.
    Ensminger W, Niederhuber J, Gyves J, Thrall J, Cozzi E, Doan K: Effective control of liver metastases from colon cancer with an implanted system for hepatic arterial chemotherapy. (Abstract) Proc Am Soc Clin Oncol 1: 1982.Google Scholar
  20. 20.
    Cohen AM, Kaufman SD, Wood WC, Greenfield AJ: Regional hepatic chemotherapy using an implantable drug infusion pump. Am J Surg 529–533, 1983.Google Scholar
  21. 21.
    Michels NA: Blood supply and anatomy of upper abdominal organs with descriptive atlas. JB Lippincott Co, Philadelphia, 1955, pp. 581.Google Scholar
  22. 22.
    Narsete T, Ansfield F, Wirtanen G, Ramirez G, Wolberg W, Jarrett F: Gastric ulceration in patients receiving intrahepatic infusion of 5-fluorouracil. Ann Surg 186: 734–736, 1977.PubMedCrossRefGoogle Scholar
  23. 23.
    Grage TB, Vassilopoulos PP, Shingleton WW, Jubert AV, Elias EG, Aust JB, Moss SE: Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracii versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A central oncology group study. Surgery 86: 550–555, 1979.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • John M. Daly
  • Nancy Kemeny

There are no affiliations available

Personalised recommendations